Functional analysis of the actin-binding protein, tropomyosin I, in neuroblastoma

British Journal of Cancer

Volumn 89, Issue 5, 2003, Pages 860-863

  Yager, M L ^a,b   Hughes, J A I ^a,c   Lovicu, F J ^b   Gunning, P W ^a,c   Weinberger, R P ^a,c   O'Neill, G M ^a,c  

^a CHILDREN S HOSPITAL AT WESTMEAD   (Australia)

^b UNIVERSITY OF SYDNEY   (Australia)

^c University of Sydney   (Australia)

Author keywords

Actin; Cytoskeleton; Neuroblastoma; Tropomyosin

Indexed keywords

ACTIN BINDING PROTEIN; TROPOMYOSIN; TROPOMYOSIN 1; UNCLASSIFIED DRUG;

ACTIN FILAMENT; ARTICLE; CELL STRUCTURE; CELL TRANSFORMATION; CONTROLLED STUDY; DOWN REGULATION; HUMAN; HUMAN CELL; NEUROBLASTOMA; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION;

ACTINS; BLOTTING, WESTERN; CELL TRANSFORMATION, NEOPLASTIC; CYTOSKELETON; DOWN-REGULATION; DROSOPHILA PROTEINS; FLUORESCENT ANTIBODY TECHNIQUE; HUMANS; NEUROBLASTOMA; NEURONS; PROTO-ONCOGENE PROTEINS C-MYC; TRANSFECTION; TROPOMYOSIN; TUMOR CELLS, CULTURED;

EID: 0141507057     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjc.6601201     Document Type: Article

References (22)

1. Bhattacharya B, Prasad GL, Valverius EM, Salomon DS, Cooper HL (1990) Tropomyosins of human mammary epithelial cells: consistent defects of expression in mammary carcinoma cell lines. Cancer Res 50: 2105-2112
2. Biedler JL, Helson L, Spengler BA (1973) Morphology and growth, tumorigenicity, and cytogenetics of human neuroblastoma cells in continuous culture. Cancer Res 33: 2643-2652
3. Boyd J, Risinger JI, Wiseman RW, Merrick BA, Selkirk JK, Barrett JC (1995) Regulation of microfilament organization and anchorage-independent growth by tropomyosin 1. Proc Natl Acad Sci USA 92: 11534-11538
4. Braverman RH, Cooper HL, Lee HS, Prasad GL (1996) Anti-oncogenic effects of tropomyosin: isoform specificity and importance of protein coding sequences. Oncogene 13: 537-545
5. Cooper HL, Feuerstein N, Noda M, Bassin RH (1985) Suppression of tropomyosin synthesis, a common biochemical feature of oncogenesis by structurally diverse retroviral oncogenes. Mol Cell Biol 5: 972-983
6. Goodman LA, Liu BC, Thiele CJ, Schmidt ML, Cohn SL, Yamashiro JM, Pai DS, Ikegaki N, Wada RK (1997) Modulation of N-myc expression alters the invasiveness of neuroblastoma. Clin Exp Metastasis 15: 130-139
7. Gunning P, Hardeman E, Jeffrey P, Weinberger R (1998) Creating intracellular structural domains: spatial segregation of actin and tropomyosin isoforms in neurons. BioEssays 20: 892-900
8. Hendricks M, Weintraub H (1981) Tropomyosin is decreased in transformed cells. Proc Natl Acad Sci USA 78: 5633-5637
9. Hughes JAI, Cooke-Yarborough CM, Chadwick NC, Schevzov G, Arbuckle S M, Gunning P, Weinberger R (2003) High molecular weight tropomyosins localize to the contractile rings of dividing cells but are absent from malignant paediatric and adult CNS tumours. Glia 42: 25-35
10. Lin JJ, Warren KS, Wamboldt DD, Wang T, Lin JL (1997) Tropomyosin isoforms in nonmuscle cells. Int Rev Cytol 170: 1-38
11. Mahadev K, Raval G, Bharadwaj S, Willingham MC, Lange EM, Vonderhaar B, Salomon D, Prasad GL (2002) Suppression of the transformed phenotype of breast cancer by tropomyosin-1. Exp Cell Res 279: 40-51
12. Masuda A, Takenaga K, Kondoh F, Fukami H, Utsumi K, Okayama H (1996) Role of a signal transduction pathway which controls disassembly of microfilament bundles and suppression of high-molecular-weight tropomyosin expression in oncogenic transformation of NRK cells. Oncogene 12: 2081-2088
13. Nikolopoulos SN, Spengler BA, Kisselbach K, Evans AE, Biedler JL, Ross RA (2000) The human non-muscle alpha-actinin protein encoded by the ACTN4 gene suppresses tumorigenicity of human neuroblastoma cells. Oncogene 19: 380-386
14. Pawlak G, Helfman DM (2001) Cytoskeletal changes in cell transformation and tumorigenesis. Curr Opin Genet Dev 11: 41-47
15. Polte TR, Hanks SK (1997) Complexes of focal adhesion kinase (FAK) and Crk-associated substrate (p130(Cas)) are elevated in cytoskeleton-associated fractions following adhesion and Src transformation. Requirements for Src kinase activity and FAK proline-rich motifs. J Biol Chem 272: 5501-5509
16. Prasad GL, Fuldner RA, Cooper HL (1993) Expression of transduced tropomyosin 1 cDNA suppresses neoplastic growth of cells transformed by the ras oncogene. Proc Natl Acad Sci USA 90: 7039-7043
17. Prasad GL, Masuelli L, Raj MH, Harindranath N (1999) Suppression of src-induced transformed phenotype by expression of tropomyosin-1. Oncogene 18: 2027-2031
18. Ross RA, Spengler BA, Domenech C, Porubcin M, Rettig WJ, Biedler JL (1995) Human neuroblastoma I-type cells are malignant neural crest stem cells. Cell Growth Differ 6: 449-456
19. Schevzov G, Gunning P, Jeffrey PL, Temm-Grove C, Helfman DM, Lin JJ, Weinberger RP (1997) Tropomyosin localization reveals distinct populations of microfilaments in neurites and growth cones. Mol Cell Neurosci 8: 439-454
20. Shah V, Bharadwaj S, Kaibuchi K, Prasad GL (2001) Cytoskeletal organization in tropomyosin-mediated reversion of ras-transformation: evidence for Rho kinase pathway. Oncogene 20: 2112-2121
21. Spengler BA, Lazarova DL, Ross RA, Biedler JL (1997) Cell lineage and differentiation state are primary determinants of MYCN gene expression and malignant potential in human neuroblastoma cells. Oncol Res 9: 467-476
22. Wang FL, Wang Y, Wong WK, Liu Y, Addivinola FJ, Liang P, Chen LB, Kantoff PW, Pardee AB (1996) Two differentially expressed genes in normal human prostate tissue and in carcinoma. Cancer Res 56: 3634-3637